Recent Developments under 340B Program
Natalia Mazina
APRIL 25, 2023
reduction to payments for most drugs purchased through the 340B Program and paid under the Outpatient Prospective Payment System (“OPPS”). Further litigation related to the remedies for the past payment cuts is continuing in the US District Court for the District of Columbia. 10,272 (Mar. Sanofi Aventis U.S. 2023) 58 F.4th
Let's personalize your content